Drew Weissman, 2023

“As important as the vaccine is, if you don’t take it, it doesn’t work!”

A scientific advance can reach a laboratory milestone long before it reaches the people it is intended to help. Drew Weissman addressed that gap in an interview with Nobel Prize Outreach’s Adam Smith on October 2, 2023, following the announcement of his shared medicine prize with Katalin Karikó. The conversation moved from their collaboration to his work on communicating about vaccines. In explaining a group formed to address hesitancy and misinformation, he made the point featured here. The official transcript contains the sentence as part of a longer response, and Nobel Prize educational materials present this concise version. Contemporary reporting also preserved the same words. The remark is about the connection between a developed vaccine and its actual use. It does not supply a personal recommendation, a guarantee of protection, or evidence that every product performs identically. Its emphasis is practical: an achievement cannot provide its intended individual benefit while remaining unused.

The sentence can sound obvious, yet the space between availability and participation contains much of the difficult work of public health. Someone may have questions that a technical announcement does not answer. Another person may understand the information but struggle to reach an appointment. A reader may encounter contradictory claims and need help distinguishing reliable evidence from confident assertion. Those situations require different responses. Repeating a slogan to each person would miss the problem the quotation makes visible. Clear explanations should describe what is established, acknowledge relevant uncertainty and allow questions without humiliation. Practical arrangements must also make participation possible. These are implications of the communication problem, not additional statements attributed to Weissman. His Nobel interview discusses whether the prize might influence people who remain uncertain while valuing science. That narrower context matters: he was considering how scientific recognition could help a conversation, rather than claiming an award settles every concern.

For anyone communicating about health, the quotation offers a test of whether a message has reached its purpose. Has a person received information they can understand and use, or merely been exposed to an impressive announcement? The distinction applies to how research is explained, how questions are answered and how services connect with their intended users. A respectful conversation can identify the specific issue that needs attention instead of treating all hesitation as the same. It also keeps research claims separate from decisions requiring appropriate professional guidance and attention to a person’s situation. The article’s interest is that bridge between knowledge and action, not a current vaccination schedule. Weissman’s words remind readers that public benefit requires more than discovery alone. Communication and practical delivery are part of the work through which an advance becomes available in ordinary life. The challenge is to preserve scientific accuracy while making the path from information to participation understandable.